Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites - PubMed

Review

Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites

George Cruzan et al. Regul Toxicol Pharmacol. 2002 Jun.

Abstract

Mice are particularly sensitive to respiratory tract toxicity following styrene exposure. Inhalation of styrene by mice results in cytotoxicity in terminal bronchioles, followed by increased incidence of bronchioloalveolar tumors, as well as degeneration and atrophy of nasal olfactory epithelium. In rats, no effects on terminal bronchioles are seen, but effects in the nasal olfactory epithelium do occur, although to a lesser degree and from higher exposure concentrations. In addition, cytotoxicity and tumor formation are not related to blood levels of styrene or styrene oxide (SO) as measured in chronic studies. Whole-body metabolism studies have indicated major differences in styrene metabolism between rats and mice. The major differences are 4- to 10-fold more ring-oxidation and phenylacetaldehyde pathways in mice compared to rats. The data indicate that local metabolism of styrene is responsible for cytotoxicity in the respiratory tract. Cytotoxicity is seen in tissues that are high in CYP2F P450 isoforms. These tissues have been demonstrated to produce a high ratio of R-SO compared to S-SO (at least 2.4 : 1). In other rat tissues the ratio is less than 1, while in mouse liver the ratio is about 1.1. Inhibition of CYP2F with 5-phenyl-1-pentyne prevents the styrene-induced cytotoxicity in mouse terminal bronchioles and nasal olfactory epithelium. R-SO has been shown to be more toxic to mouse terminal bronchioles than S-SO. In addition, 4-vinylphenol (ring oxidation of styrene) has been shown to be highly toxic to mouse terminal bronchioles and is also metabolized by CYP2F. In human nasal and lung tissues, styrene metabolism to SO is below the limit of detection in nearly all samples, and the most active sample of lung was approximately 100-fold less active than mouse lung tissue. We conclude that styrene respiratory tract toxicity in mice and rats, including mouse lung tumors, are mediated by CYP2F-generated metabolites. The PBPK model predicts that humans do not generate sufficient levels of these metabolites in the terminal bronchioles to reach a toxic level. Therefore, the postulated mode of action for these effects indicates that respiratory tract effects in rodents are not relevant for human risk assessment.

Similar articles

• Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.

  Cruzan G, Bus J, Banton M, Gingell R, Carlson G. Cruzan G, et al. Regul Toxicol Pharmacol. 2009 Nov;55(2):205-18. doi: 10.1016/j.yrtph.2009.07.002. Epub 2009 Jul 7. Regul Toxicol Pharmacol. 2009. PMID: 19589367 Review.

• Physiologically based pharmacokinetic modeling of styrene and styrene oxide respiratory-tract dosimetry in rodents and humans.

  Sarangapani R, Teeguarden JG, Cruzan G, Clewell HJ, Andersen ME. Sarangapani R, et al. Inhal Toxicol. 2002 Aug;14(8):789-834. doi: 10.1080/08958370290084647. Inhal Toxicol. 2002. PMID: 12122565

• Studies of styrene, styrene oxide and 4-hydroxystyrene toxicity in CYP2F2 knockout and CYP2F1 humanized mice support lack of human relevance for mouse lung tumors.

  Cruzan G, Bus J, Hotchkiss J, Sura R, Moore C, Yost G, Banton M, Sarang S. Cruzan G, et al. Regul Toxicol Pharmacol. 2013 Jun;66(1):24-9. doi: 10.1016/j.yrtph.2013.02.008. Epub 2013 Feb 27. Regul Toxicol Pharmacol. 2013. PMID: 23454103

• CYP2F2-generated metabolites, not styrene oxide, are a key event mediating the mode of action of styrene-induced mouse lung tumors.

  Cruzan G, Bus J, Hotchkiss J, Harkema J, Banton M, Sarang S. Cruzan G, et al. Regul Toxicol Pharmacol. 2012 Feb;62(1):214-20. doi: 10.1016/j.yrtph.2011.10.007. Epub 2011 Oct 21. Regul Toxicol Pharmacol. 2012. PMID: 22041433

Cited by

• Comparison of acute respiratory epithelial toxicity for 4-Methylimidazole and naphthalene administered by oral gavage in B6C3F1 mice.

  Kelty JS, Keum C, Brown VJ, Edwards PC, Carratt SA, Van Winkle LS. Kelty JS, et al. Regul Toxicol Pharmacol. 2020 Oct;116:104761. doi: 10.1016/j.yrtph.2020.104761. Epub 2020 Aug 5. Regul Toxicol Pharmacol. 2020. PMID: 32768664 Free PMC article.

• Metabolism of styrene to styrene oxide and vinylphenols in cytochrome P450 2F2- and P450 2E1-knockout mouse liver and lung microsomes.

  Shen S, Li L, Ding X, Zheng J. Shen S, et al. Chem Res Toxicol. 2014 Jan 21;27(1):27-33. doi: 10.1021/tx400305w. Epub 2013 Dec 19. Chem Res Toxicol. 2014. PMID: 24320693 Free PMC article.

• Chemical Composition and Cytotoxic Activity of the Essential Oil and Oleoresins of In Vitro Micropropagated Ansellia africana Lindl: A Vulnerable Medicinal Orchid of Africa.

  Saleh-E-In MM, Bhattacharyya P, Van Staden J. Saleh-E-In MM, et al. Molecules. 2021 Jul 28;26(15):4556. doi: 10.3390/molecules26154556. Molecules. 2021. PMID: 34361724 Free PMC article.

• Role of metabolic activation and the TRPA1 receptor in the sensory irritation response to styrene and naphthalene.

  Lanosa MJ, Willis DN, Jordt S, Morris JB. Lanosa MJ, et al. Toxicol Sci. 2010 Jun;115(2):589-95. doi: 10.1093/toxsci/kfq057. Epub 2010 Feb 22. Toxicol Sci. 2010. PMID: 20176620 Free PMC article.

• Editor's Highlight: Complete Attenuation of Mouse Lung Cell Proliferation and Tumorigenicity in CYP2F2 Knockout and CYP2F1 Humanized Mice Exposed to Inhaled Styrene for up to 2 Years Supports a Lack of Human Relevance.

  Cruzan G, Bus JS, Banton MI, Sarang SS, Waites R, Layko DB, Raymond J, Dodd D, Andersen ME. Cruzan G, et al. Toxicol Sci. 2017 Oct 1;159(2):413-421. doi: 10.1093/toxsci/kfx141. Toxicol Sci. 2017. PMID: 28962520 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information